Sartorius VZ: This is a trend-strong stock. Now targeting a growth phase for the laboratory supplier starting in 2025. Order intake +21.5% in the 4th quarter!
Reading Time: 1 minute
A topic in the stock market is the end of inventory correction among laboratory equipment suppliers. In 2023 and 2024, the effects of the COVID-19 pandemic persisted, during which many diagnostic capacities were created. Now, demand is beginning to rise again, as Sartorius VZ (716563) demonstrated with a 21.5% increase in order intake in the 4th quarter. The demand for solutions for the production of biopharmaceuticals had a positive impact. Sartorius VZ aims to grow faster than the market and gain market share by 2025. Thermo Fisher also presented...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.